NASDAQ:BNR Burning Rock Biotech Q2 2026 Earnings Results & Report $13.27 -0.05 (-0.38%) Closing price 11/20/2026 03:58 PM EasternExtended Trading$13.28 +0.02 (+0.11%) As of 11/20/2026 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Burning Rock Biotech beat analyst expectations on both earnings and revenue in its Q2 2026 results, released September 10, 2026. The company reported EPS of -$0.20 versus the -$2.2883 consensus estimate, while revenue of $19.84 million topped the $19.21 million estimate by $630.03 thousand. Research:ProfileEarnings HistoryForecast Earnings Announcement Details QuarterQ2 2026Report DateSeptember 10, 2026TimeBefore Market OpensConference Call7:00 AM ET Burning Rock Biotech EPS ResultsActual EPS-$0.20Consensus EPS -$2.2883Beat/MissBeat by +$2.0883One Year Ago EPSN/ABurning Rock Biotech Revenue ResultsActual Revenue$19.84 millionExpected Revenue$19.21 millionBeat/MissBeat by +$630.03 thousandYoY Revenue GrowthN/AUpcoming EarningsBurning Rock Biotech's Q3 2026 earnings is estimated for Monday, November 23, 2026, based on past reporting schedules, with a conference call scheduled on Friday, November 27, 2026 at 12:30 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.Conference Call ResourcesSlide DeckPress Release (6-K)Earnings HistoryCompany ProfileSlide DeckFull Screen Slide DeckPowered by Earnings DocumentsPress Release(6-K) Burning Rock Biotech Q2 2026 Earnings FAQ Did Burning Rock Biotech beat earnings estimates for Q2 2026? Burning Rock Biotech (NASDAQ:BNR) reported earnings of -$0.20 per share for Q2 2026, beating the consensus estimate of -$2.2883. The report was announced on Thursday, September 10, 2026. What was Burning Rock Biotech's revenue for Q2 2026? Burning Rock Biotech reported revenue of $19.84 million for Q2 2026, against a consensus estimate of $19.21 million. When is Burning Rock Biotech's next earnings date? Burning Rock Biotech's next earnings date is estimated for Monday, November 23, 2026. MarketBeat tracks confirmed and estimated earnings dates for Burning Rock Biotech on the company's earnings history page. Burning Rock Biotech Earnings HeadlinesBurning Rock Announces 2026 Annual General Meeting to be Held on December 22, 2026November 17, 2026 | globenewswire.comBurning Rock Biotech (BNR) versus Its Competitors Critical AnalysisNovember 17, 2026 | americanbankingnews.comWorse than socialismDonald Trump and Bernie Sanders rarely agree on anything, yet both are steering the country toward the same economic system, according to veteran analyst Porter Stansberry. The government has already taken stakes in companies like Intel, Lithium Americas, and MP Materials, while political rhetoric on both sides points toward deeper centralization. Stansberry has spent months investigating what this bipartisan shift could mean for investors navigating the months ahead. | Porter & Company (Ad)Burning Rock Biotech (BNR) Projected to Release Earnings on TuesdayNovember 16, 2026 | americanbankingnews.comBurning Rock Biotech Ltd (BNR) Shares Surge 3.3% -- What GF Score of 53 Tells InvestorsSeptember 25, 2026 | gurufocus.comBurning Rock Q2 Revenue Falls 9%; In-Hospital Business Posts GrowthSeptember 10, 2026 | rttnews.comSee More Burning Rock Biotech Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Burning Rock Biotech? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Burning Rock Biotech and other key companies, straight to your email. Email Address About Burning Rock BiotechBurning Rock Biotech (NASDAQ:BNR) is a precision oncology company that develops and provides next-generation sequencing tests for cancer. Its testing uses tissue and blood samples to help inform treatment decisions, monitor disease and support cancer research. The company also provides research and clinical-trial services to pharmaceutical companies, including support for the development of cancer therapies and diagnostic tests. Burning Rock is headquartered in Guangzhou, China, and its business primarily serves the Chinese healthcare and life sciences markets. Founded in 2014, Burning Rock focuses on applying genomic testing to cancer care, including the development of tests for treatment selection and disease monitoring.View Burning Rock Biotech ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles MarketBeat Week in Review – 11/16 - 11/20If NVIDIA Tightens Its Wallet, These 3 Stocks Could Feel ItZIM Just Posted Huge Profits, But Its $35 Buyout Is Still in LimboAirfares Are Up, Flights Are Tight: 3 Airline Stocks Facing a Winter TestOwens Corning's Stock Slump May Have a Silver Lining for Dividend InvestorsThe Patchpocalypse Could Be a Big Opportunity for These 2 Cybersecurity StocksHard Drives Were Left for Dead, But Seagate and Western Digital Are Soaring Upcoming Earnings Hewlett Packard Enterprise (11/23/2026)Medtronic (11/24/2026)Analog Devices (11/24/2026)Autodesk (11/24/2026)Dell Technologies (11/24/2026)Deere & Company (11/25/2026)CrowdStrike (12/1/2026)Marvell Technology (12/1/2026)Bank Of Montreal (12/2/2026)Bank of Nova Scotia (12/2/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.